Maven Securities’s 89bio ETNB Stock Holding History

Maven Securities’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,000	Closed	-$116K	–	931
2022 Q3	$116K	Sell	20,000 -280,000	-93%	-$1.23M	﹤0.01%	1067
2022 Q2	$966K	Buy	+300,000	New	+$906K	0.03%	372

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Maven Securities's ETNB Position: Q4 2022 in Review

Maven Securities sold out of 89bio (ETNB) in Q4 2022, closing a stake of 20,000 shares — an estimated $116K sold.

Maven Securities first reported a position in ETNB in Q2 2022 and held it in 2 quarters. The position peaked at $966K in Q2 2022. 106 funds tracked by Wall St. Rank hold ETNB as of Q4 2022.

Maven Securities reported no remaining 89bio position as of Q4 2022 after selling out during the quarter.
Maven Securities sold 20,000 89bio shares in Q4 2022, an estimated $116K.
Maven Securities first reported a position in 89bio in Q2 2022 and held it in 2 quarters.
Maven Securities's 89bio position peaked at $966K in Q2 2022.
106 funds tracked by Wall St. Rank held 89bio as of Q4 2022.

Based on Maven Securities's 13F filing for Q4 2022, filed 14 Feb 2023.